These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 9581779

  • 21. Divergent regulation of HIV-1 replication in PBMC of infected individuals by CC chemokines: suppression by RANTES, MIP-1alpha, and MCP-3, and enhancement by MCP-1.
    Vicenzi E, Alfano M, Ghezzi S, Gatti A, Veglia F, Lazzarin A, Sozzani S, Mantovani A, Poli G.
    J Leukoc Biol; 2000 Sep; 68(3):405-12. PubMed ID: 10985258
    [Abstract] [Full Text] [Related]

  • 22. Susceptibility of in vitro stimulated PBMC to infection with NSI HIV-1 is associated with levels of CCR5 expression and beta-chemokine production.
    Blaak H, Ran LJ, Rientsma R, Schuitemaker H.
    Virology; 2000 Feb 15; 267(2):237-46. PubMed ID: 10662619
    [Abstract] [Full Text] [Related]

  • 23. Nonproductive human immunodeficiency virus type 1 infection of human fetal astrocytes: independence from CD4 and major chemokine receptors.
    Sabri F, Tresoldi E, Di Stefano M, Polo S, Monaco MC, Verani A, Fiore JR, Lusso P, Major E, Chiodi F, Scarlatti G.
    Virology; 1999 Nov 25; 264(2):370-84. PubMed ID: 10562499
    [Abstract] [Full Text] [Related]

  • 24. Heterozygous defect in HIV-1 coreceptor CCR5 and chemokine production.
    Yang JY, Togni M, Widmer U.
    Cytokine; 1999 Jan 25; 11(1):1-7. PubMed ID: 10080873
    [Abstract] [Full Text] [Related]

  • 25. Expression of chemokine receptors CXCR4 and CCR5 in HIV-1-infected and uninfected individuals.
    Ostrowski MA, Justement SJ, Catanzaro A, Hallahan CA, Ehler LA, Mizell SB, Kumar PN, Mican JA, Chun TW, Fauci AS.
    J Immunol; 1998 Sep 15; 161(6):3195-201. PubMed ID: 9743388
    [Abstract] [Full Text] [Related]

  • 26. Increased CCR5 expression with decreased beta chemokine secretion in Ethiopians: relevance to AIDS in Africa.
    Kalinkovich A, Weisman Z, Leng Q, Borkow G, Stein M, Greenberg Z, Zlotnikov S, Eitan S, Bentwich Z.
    J Hum Virol; 1999 Sep 15; 2(5):283-9. PubMed ID: 10551734
    [Abstract] [Full Text] [Related]

  • 27. Reduced prevalence of the CCR5 delta32 heterozygous genotype in human immunodeficiency virus-infected individuals with AIDS dementia complex.
    van Rij RP, Portegies P, Hallaby T, Lange JM, Visser J, de Roda Husman AM, van 't Wout AB, Schuitemaker H.
    J Infect Dis; 1999 Sep 15; 180(3):854-7. PubMed ID: 10438379
    [Abstract] [Full Text] [Related]

  • 28. CXCR4 and CCR5 expression on CD4+ T cells in vivo and HIV-1 antigen beta-chemokine production in vitro after treatment with HIV-1 immunogen (REMUNE).
    Moss RB, Giermakowska WK, Diveley JP, Savary JR, Wallace MR, Maigetter RZ, Jensen FC, Carlo DJ.
    J Hum Virol; 2000 Sep 15; 3(1):44-9. PubMed ID: 10774806
    [Abstract] [Full Text] [Related]

  • 29. Increased Levels of Macrophage Inflammatory Proteins Result in Resistance to R5-Tropic HIV-1 in a Subset of Elite Controllers.
    Walker WE, Kurscheid S, Joshi S, Lopez CA, Goh G, Choi M, Barakat L, Francis J, Fisher A, Kozal M, Zapata H, Shaw A, Lifton R, Sutton RE, Fikrig E.
    J Virol; 2015 May 15; 89(10):5502-14. PubMed ID: 25740989
    [Abstract] [Full Text] [Related]

  • 30. Up-regulation of HIV coreceptors CXCR4 and CCR5 on CD4(+) T cells during human endotoxemia and after stimulation with (myco)bacterial antigens: the role of cytokines.
    Juffermans NP, Paxton WA, Dekkers PE, Verbon A, de Jonge E, Speelman P, van Deventer SJ, van der Poll T.
    Blood; 2000 Oct 15; 96(8):2649-54. PubMed ID: 11023494
    [Abstract] [Full Text] [Related]

  • 31. Genetic subtype-independent inhibition of human immunodeficiency virus type 1 replication by CC and CXC chemokines.
    Trkola A, Paxton WA, Monard SP, Hoxie JA, Siani MA, Thompson DA, Wu L, Mackay CR, Horuk R, Moore JP.
    J Virol; 1998 Jan 15; 72(1):396-404. PubMed ID: 9420238
    [Abstract] [Full Text] [Related]

  • 32. Endogenous production of beta-chemokines by CD4+, but not CD8+, T-cell clones correlates with the clinical state of human immunodeficiency virus type 1 (HIV-1)-infected individuals and may be responsible for blocking infection with non-syncytium-inducing HIV-1 in vitro.
    Saha K, Bentsman G, Chess L, Volsky DJ.
    J Virol; 1998 Jan 15; 72(1):876-81. PubMed ID: 9420304
    [Abstract] [Full Text] [Related]

  • 33. Prevalence of a 32 bp deletion in the gene for human immunodeficiency virus 1 co-receptor CCR5 in Slovak population.
    Takácová M, Nogová P, Hábeková M, Staneková D.
    Acta Virol; 2008 Jan 15; 52(4):261-4. PubMed ID: 19143484
    [Abstract] [Full Text] [Related]

  • 34. Increased turnover of CCR5+ and redistribution of CCR5- CD4 T lymphocytes during primary human immunodeficiency virus type 1 infection.
    Zaunders JJ, Kaufmann GR, Cunningham PH, Smith D, Grey P, Suzuki K, Carr A, Goh LE, Cooper DA.
    J Infect Dis; 2001 Mar 01; 183(5):736-43. PubMed ID: 11181150
    [Abstract] [Full Text] [Related]

  • 35. The role of dendritic cells in the infection of CD4+ T cells with the human immunodeficiency virus: use of dendritic cells from individuals homozygous for the delta32CCR5 allele as a model.
    Dybul M, Weissman D, Rubbert A, Machado E, Cohn M, Ehler L, O'Callahan M, Mizell S, Fauci AS.
    AIDS Res Hum Retroviruses; 1998 Sep 01; 14(13):1109-13. PubMed ID: 9737582
    [Abstract] [Full Text] [Related]

  • 36. Reduced CD4 T cell activation and in vitro susceptibility to HIV-1 infection in exposed uninfected Central Africans.
    Bégaud E, Chartier L, Marechal V, Ipero J, Léal J, Versmisse P, Breton G, Fontanet A, Capoulade-Metay C, Fleury H, Barré-Sinoussi F, Scott-Algara D, Pancino G.
    Retrovirology; 2006 Jun 22; 3():35. PubMed ID: 16792805
    [Abstract] [Full Text] [Related]

  • 37. Changes in CCR5 and CXCR4 expression and beta-chemokine production in HIV-1-infected patients treated with highly active antiretroviral therapy.
    Pierdominici M, Giovannetti A, Ensoli F, Mazzetta F, Marziali M, De Cristofaro MR, Santini-Muratori D, Leti W, Aiuti F.
    J Acquir Immune Defic Syndr; 2002 Feb 01; 29(2):122-31. PubMed ID: 11832680
    [Abstract] [Full Text] [Related]

  • 38. CCR5 genotype and plasma beta-chemokine concentration of Brazilian HIV-infected individuals.
    Mikawa AY, Tagliavini SA, Costa PI.
    Braz J Med Biol Res; 2002 Nov 01; 35(11):1333-7. PubMed ID: 12426633
    [Abstract] [Full Text] [Related]

  • 39. High levels of CC-chemokine expression and downregulated levels of CCR5 during HIV-1/HTLV-1 and HIV-1/HTLV-2 coinfections.
    Oo Z, Barrios CS, Castillo L, Beilke MA.
    J Med Virol; 2015 May 01; 87(5):790-7. PubMed ID: 25678365
    [Abstract] [Full Text] [Related]

  • 40. Antigen stimulation induces HIV envelope gp120-specific CD4(+) T cells to secrete CCR5 ligands and suppress HIV infection.
    Kaur G, Tuen M, Virland D, Cohen S, Mehra NK, Münz C, Abdelwahab S, Garzino-Demo A, Hioe CE.
    Virology; 2007 Dec 05; 369(1):214-25. PubMed ID: 17765942
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.